On track to present data from key clinical studies of azenosertib in the fourth quarter of 2024
https://www.globenewswire.com/news-release/2024/09/16/2946475/0/en/Zentalis-Pharmaceuticals-Announces-FDA-Has-Lifted-Partial-Clinical-Hold-on-Azenosertib-Studies.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.